pylori : inhibition of the radical SAM enzyme MqnE in menaquinone biosynthesis
Emibetuzumab (LY2875358) against c-Met and HGF and MP0250 against HGF and VEGF are two bispecific antibodies that prevent c-Met attachment to the ligand, increase the internalization, destroy c-Met molecules, and thereby reduce the signaling of the c-Met pathway [149, 174, 175]
[3] Sikiric P, Udovicic M, Barisic, I et al
This result is associated with an immunomodulatory process (reduced expression of cytokines such as IL-8 and TNF-) (Shen et al., 2023)
Agarwal A, Gupta S, Sharma RK: Role of oxidative stress in female reproduction
It also helps protect cells from further harm by reducing inflammation and defending against microbes